PharmaShots

APRIL 28, 2023

Difficile Infection Date: Apr 27, 2023 | Tags: Seres Therapeutics, Nestlé Health Science, Vowst, C.

FDA 56

FDA 56

PharmaShots

MARCH 31, 2023

PDS Biotech to Initiate P-III Trial (VERSATILE-003) of PDS0101 + Keytruda (pembrolizumab) for Head and Neck Cancer Date: Mar 31, 2023 | Tags: PDS Biotech, PDS0101, Keytruda, pembrolizumab, Head, Neck Cancer, Clinical Trial, P-III, VERSATILE-003 Trial Omega Therapeutics Entered into a Clinical Supply Agreement with Roche to Evaluate OTX-2002 for Hepatocellular (..)

FDA 40

FDA 40

PharmaShots

MARCH 24, 2023

PTC Therapeutics’ Upstaza (eladocagene exuparvovec) Receives NICE Recommendation for the Treatment of AADC Deficiency Date: Mar 24, 2023 | Tags: PTC Therapeutics, Upstaza, eladocagene exuparvovec, AADC Deficiency, Regulatory, NICE Onconova Therapeutics Entered into a Research Collaboration with Pangea Biomed to Identify Biomarkers for Cancer (..)

FDA 40

FDA Immunization 40

PharmaShots

JUNE 23, 2023

Gilead Receives EMA’s CHMP Positive Opinion of Trodelvy (sacituzumab govitecan) for Pre-Treated HR+/HER2- Metastatic Breast Cancer Date: June 23, 2023 | Tags: Gilead, Trodelvy, sacituzumab govitecan, HR+/HER2- Metastatic Breast Cancer, Regulatory, EMA, CHMP, Positive Opinion Sarepta Therapeutics’ Elevidys Receives the US FDA’s Accelerated (..)

FDA 40

FDA 40

PharmaShots

FEBRUARY 3, 2023

4D Molecular Therapeutics Receives the US FDA’s IND Clearance of 4D-150 for the Treatment of Diabetic Macular Edema Date: Feb 03, 2023 | Tags: 4D Molecular Therapeutics, 4D-150, Diabetic Macular Edema, Regulatory, US, FDA, IND AstraZeneca and Amgen Receive the US FDA’s Approval of Tezspire (tezepelumab) for the Treatment of Severe Asthma (..)

FDA 40

FDA Labelling 40

PharmaShots

APRIL 14, 2023

Ocugen Reports Preliminary Results from the P-I/II Trial of OCU400 for the Treatment of Retinitis Pigmentosa and Leber Congenital Amaurosis Date: Apr 14, 2023 | Tags: Ocugen, OCU400, Retinitis Pigmentosa, Leber Congenital Amaurosis, Clinical Trial, P-I/II Trial Candesant Biomedical Receives the US FDA Clearance of Brella SweatControl Patch for Primary (..)

FDA 40

FDA 40

PharmaShots

JUNE 16, 2023

Date: June 12, 2023 | Tags: Novartis, Chinook Therapeutics, Atrasentan, Zigakibart, BION-1301, IgA nephropathy, M&A, ~$3.5B Date: June 12, 2023 | Tags: Novartis, Chinook Therapeutics, Atrasentan, Zigakibart, BION-1301, IgA nephropathy, M&A, ~$3.5B

FDA 40

FDA Labelling 40

PharmaShots

JANUARY 27, 2023

Magenta Therapeutics Pauses the P-I/II Study in AML Patients Date: Jan 27, 2023 | Tags: Magenta Therapeutics, MGTA-117, AML, Clinical Trial, P-I/II Ipsen Receives CHMP Negative Opinion for Palovarotene to Treat Fibrodysplasia Ossificans Progressiva Date: Jan 27, 2023 | Tags: Ipsen, Palovarotene, Fibrodysplasia Ossificans Progressiva, Regulatory, CHMP, (..)

FDA 40

FDA Immunization 40

STAT

JANUARY 31, 2024

 The announcement concerning the lower-dose starter product came as the company reported 2023 sales rose 36% and operating profit grew 44% at constant exchange rates, driven by massive sales of Wegovy and Ozempic, used to treat diabetes. Novo also projected double-digit growth in sales and operating profit for 2024.

85

85

PharmaShots

FEBRUARY 24, 2023

Positive Solid Tumors Date: Feb 23, 2023 | Tags: Keymed, Lepu Biopharma, AstraZeneca, CMG901, Claudin 18.2-Positive Positive Solid Tumors Date: Feb 23, 2023 | Tags: Keymed, Lepu Biopharma, AstraZeneca, CMG901, Claudin 18.2-Positive Positive Solid Tumors Date: Feb 23, 2023 | Tags: Keymed, Lepu Biopharma, AstraZeneca, CMG901, Claudin 18.2-Positive

FDA 40

FDA Vaccines 40

PharmaShots

JUNE 9, 2023

Quell Therapeutics Signed an Exclusive Option and License Agreement with AstraZeneca to Develop, Manufacture and Commercialize Engineered Treg Cell Therapies Date: June 09, 2023 | Tags: Quell Therapeutics, AstraZeneca, Engineered Treg Cell Therapies, Type 1 Diabetes, Inflammatory Bowel Disease, Biotech, Treg cell engineering modules Astellas and the (..)

FDA 40

FDA 40

PharmaShots

MARCH 17, 2023

5-Adapted Bivalent Booster to Treat COVID-19 in Children ≤5 Years Date: Mar 15, 2023 | Tags: Pfizer, BioNTech, Omicron BA.4/BA.5-Adapted 5-Adapted Bivalent Booster to Treat COVID-19 in Children ≤5 Years Date: Mar 15, 2023 | Tags: Pfizer, BioNTech, Omicron BA.4/BA.5-Adapted

FDA 40

FDA Labelling 40

The Checkup by Singlecare

DECEMBER 5, 2023

The #ozempic tag on TikTok has amassed over 1 billion views to date. The Type 2 diabetes medication was everywhere. In addition, the same study found that over half the patients taking Ozempic or a similar GLP-1 have a history of diabetes. When prescribed for Type 2 diabetes, Ozempic is typically covered by insurance providers.

Insurance 105

Insurance Prescription Filling FDA Dosage 105

The Checkup by Singlecare

SEPTEMBER 7, 2023

Compare Mounjaro alternatives | Other GLP-1 receptor agonists | Oral biguanides | SGLT2 inhibitors | DPP4 inhibitors | GLP-1 receptor agonists for weight loss | Natural alternatives | How to switch meds Diet and exercise alone aren’t enough to control Type 2 diabetes. Fortunately, drug therapy for diabetes has come a long way.

Insurance 52

Insurance Insurance Coverage FDA Dosage 52

PharmD Live

DECEMBER 21, 2021

With an annual price per patient of nearly $56,000 per year, patients’ families are looking for solutions for their loved ones–with a huge price tag. Insulin, first introduced in 1921, 100 years later, 2021, diabetes monitoring devices are added to Medicare’s durable medical equipment list coverage. See it here. All rights reserved.

FDA 52

FDA Hospitals 52

The Checkup by Singlecare

AUGUST 31, 2023

How to get Mounjaro without insurance Mounjaro (tirzepatide) is a brand-name prescription drug FDA-approved to control blood sugar levels in people with Type 2 diabetes. Some insurance plans and Medicare Part D drug plans cover Mounjaro for Type 2 diabetes, but some don’t. With a monthly price tag of $1,580, Mounjaro is no exception.

Insurance 98

Insurance Compounding Insurance Coverage Labelling 98

Pharmaceutical Technology

JANUARY 17, 2023

Despite its high price tag, bimagrumab’s unique features set it apart from currently marketed therapies. Mounjaro is anticipated to launch in the US later this year or by early 2024.

Hospitals 52

Hospitals 52

The Checkup by Singlecare

NOVEMBER 2, 2023

These drugs mimic GLP-1, a hormone responsible for regulating appetite and food intake, leading to weight loss and improved control of blood sugar levels in people with Type 2 diabetes. So how do you know if they’re right for your patients (even those who aren’t diabetic)? Rising demand for GLP-1 drugs: Why are they so popular?

Insurance 52

Insurance FDA Adverse Reactions Hospitals 52

The Checkup by Singlecare

JANUARY 11, 2024

Read more about treatments for skin tags , hidradenitis suppurativa , and shingles. Growths “Growths such as cysts, skin tags, and moles can also cause pain when they’re inflamed,” says Brendan Camp, MD , a dermatologist with MDCS Dermatology in New York. Armpit pain can be managed with cold compresses, rest, and sometimes medication.

Mayo Clinic 52

Mayo Clinic Vaccines Immunization 52

PharmD Live

JANUARY 25, 2022

Diabetes 2, low quality of life, cardiac-related illnesses, osteoarthritis, and more are caused or exacerbated by obesity. During a Routine Flu Shot, a Pharmacist Saves a Patient’s Life Lisa Boylan |Mar-22-18|Categories: Article |Tags: Pharmacy_Value [link]. Improved Diagnostics and Patient Outcomes – [link]. Dean, Troy C.

Adverse Reactions 52

Adverse Reactions Patient Care Communication Hospitals 52

The Checkup by Singlecare

MARCH 21, 2023

Belbuca is a good alternative to opioid treatment that needs to be taken around the clock, but it may come with a hefty price tag. mg to 2 mg every 4 hours as needed – adjust according to response IM, SubQ: 0.2 If cost is a concern, using a SingleCare prescription discount card can aid in saving you money at your local pharmacy.

Dosage 52

Dosage Controlled Substances Labelling Packaging 52

PharmaShots

MARCH 10, 2023

Vertex Receives the US FDA’s IND Clearance of VX-264 for the Treatment of Type 1 Diabetes Date: Mar 10, 2023 | Tags: Vertex, VX-264, Type 1 Diabetes, Regulatory, US, FDA, IND Alnylam Expands its Collaboration with Medison Pharma to Commercialize RNAi Therapies Date: Mar 10, 2023 | Tags: Alnylam, Medison Pharma, RNAi Therapies, Onpattro, patisiran, (..)

FDA 40

FDA Vaccines 40

The Checkup by Singlecare

JANUARY 19, 2023

People with diabetes or prediabetes experience hyperglycemia. High blood sugar is caused by various factors, such as certain foods, stress, or, more commonly for those with Type 1 diabetes , not taking enough insulin. Diabetes medications can be expensive, but there are ways to save on your medications.

Immunization 105

Immunization Hospitals Communication 105

The Checkup by Singlecare

JUNE 21, 2023

The condition causes higher levels of androgen hormone production, resulting in symptoms such as irregular menstrual cycles, acne, excess hair growth, cysts, skin tags, thinning hair, skin darkening, and infertility. In addition to eating a healthy diet and regular exercise, certain diabetes medications, including Ozempic, may help.

Insurance 98

Insurance FDA Compounding Compounding Pharmacies 98

pharmaphorum

DECEMBER 2, 2020

Others rapidly followed, including Glucotrol, aimed at diabetics, and Procardia, an anti-hypertensive. For all the latest Pfizer news follow pharmaphorum’s Pfizer tag. The 1990s and 2000s would soon take this blockbuster-based success to new levels. The post A history of Pfizer appeared first on.

Compounding 128

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 128

The Spirit Pharmacist

DECEMBER 2, 2021

However, psychedelic assisted therapy is resource intensive and will likely come with a price tag putting it out of reach of many persons that could benefit from such therapies. The RDF bought up supplies of diabetes medications from manufacturers or other NGOs specializing in the redistribution of unwanted/unneeded drugs.

Health and Personal Care Stores 52

Health and Personal Care Stores Insurance Coverage Insurance Patient Care 52

The Checkup by Singlecare

MARCH 7, 2024

It was approved by the Food and Drug Administration (FDA) in 2017 for treating Type 2 diabetes. Ozempic dosage and administration “Ozempic is a weekly subcutaneous injection sold as a multidose pen,” says Chhaya Makhija, MD , endocrinologist and lifestyle medicine specialist, and founder of Unified Endocrine and Diabetes Care in California.

Health and Personal Care Stores 52

Health and Personal Care Stores Insurance Packaging Insurance Coverage 52

pharmaphorum

DECEMBER 7, 2021

They also found that sildenafil use reduced the likelihood of Alzheimer’s in people with coronary artery disease, hypertension and type 2 diabetes – which are known risk factors for this type of dementia – but also in those without these underlying conditions.

Compounding 52

Compounding Insurance FDA 52

pharmaphorum

FEBRUARY 26, 2021

During this tenure, J&J entered into the areas of vision care, mechanical wound closure and diabetes management. For all the latest pharma news on Johnson & Johnson, follow pharmaphorum’s J&J and Janssen tags. Acquisitions post-Janssen. Between 1976 and 1989, James E. Burke was chairman and CEO of J&J.

Vaccines 116

Vaccines Labelling Communication 116

The Checkup by Singlecare

MAY 8, 2023

Belbuca is a good alternative to opioid treatment that needs to be taken around the clock, but it may come with a hefty price tag. mg to 2 mg every 4 hours as needed—adjust according to response IM, SubQ: 0.2 fibromyalgia ).

Controlled Substances 52

Controlled Substances Dosage Labelling FDA 52

Pharmaceutical Technology

NOVEMBER 30, 2022

The drug was approved to treat type 2 diabetes mellitus in May. High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. Anti-obesity therapeutic landscape.

Insurance 105

Insurance Labelling Communication FDA 105

Pharmaceutical Technology

NOVEMBER 30, 2022

The drug was approved to treat type 2 diabetes mellitus in May. High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. Anti-obesity therapeutic landscape.

Insurance 98

Insurance Labelling Communication FDA 98